|
|
 |
|
|
|
|
168. M. Cormier. Method for Reducing Sensitization or Irritation in Transdermal Drug Delivery and Means Thereof. U.S. Patent 4,885,154 (1989). |
|
|
|
|
|
|
|
|
169. T. Franz, et al. Article for the Delivery to Animal Tissue of a Pharmacologically Active Agent. U.S. Patent 5028431 (1991). |
|
|
|
|
|
|
|
|
170. P. Ledger, et al. Reduction or Prevention of Sensitization to drugs. U.S. Patent 5120545 (1992). |
|
|
|
|
|
|
|
|
171. M. Cormier, et al. Reduction or Prevention of Skin Sensitization by Drugs. U.S. Patent 5130139 (1992). |
|
|
|
|
|
|
|
|
172. M. Cormier, et al. Reduction or Prevention of Skin Irritation by Drugs. U.S. Patent 5160741 (1993). |
|
|
|
|
|
|
|
|
173. D. Wolfgang. Magnesium Salts as Topical Inflammation Inhibitors for the Skin. Ger. (East), Patent DD297062. |
|
|
|
|
|
|
|
|
174. A. Grant. Suppression of Eczematous Dermatitis by Calcium Transport Inhibitors. U.S. Patent 5202130 (1993). |
|
|
|
|
|
|
|
|
175. Site-Specific Delivery. E. Tomlinson and S. S. Davis, Eds. John Wiley, NY, 1986. |
|
|
|
|
|
|
|
|
176. I. J. Fidler, A. Raz, W. E. Fogler, K. Kroh, P. Bugelsi, and G. Poste. Cancer Res. 40: 4460, 1980. |
|
|
|
|
|
|
|
|
177. J. N. Weinstein, C. D. V. Black, J. Barbet, R. R. Eger, R. J. Parker, O. D. Hutton, J. L. Mulshinc, A. M. Keehan, S. M. Larson, J. A. Carrasquillo, S. M. Sieber, and D. G. Covell. Site-Specific Drug Delivery. E. Tomlinson and S. S. Davis, Eds. John Wiley, New York, 1988, p. 81. |
|
|
|
|
|
|
|
|
178. L. Illum, N. W. Thomas, and S. S. Davis. J. Pharm. Sci. 75: 16, 1986. |
|
|
|
|
|
|
|
|
179. J. Kopecek and R. Duncan. J. Contr. Rel. 6: 315, 1987. |
|
|
|
|
|
|
|
|
180. I. J. Fidler. Site-Specific Drug Delivery. E. Tomlinson and S. S. Davis, Eds. John Wiley, New York, 1986, p. 111. |
|
|
|
|
|
|
|
|
181. G. Kohler and C. Milstein. Continuous Cultures of Fused Cells Secreting Anti-body of Predefined Specificity. Nature 256: 495, 1975. |
|
|
|
|
|
|
|
|
182. B. F. Erlander. Pharmacol. Rev. 25: 271, 1973. |
|
|
|
|
|
|
|
|
183. E. Ishikawa. J. Immunoassay 4: 209, 1983. |
|
|
|
|
|
|
|
|
184. P. N. Kulkami, P. H. Blair, and T. Ghose. Fed. Proc. 40: 642, 1981. |
|
|
|
|
|
|
|
|
185. R. Arnon and E. Kurwitz. In Durable Resistance in Crops. F. Lamberti, et al., Eds. Plenum Press, NY, 1983, p. 23. |
|
|
|
|
|
|
|
|
186. R. K. Oldsman. J. Clin. Oncol. 1: 582, 1993. |
|
|
|
|
|
|
|
|
187. G. F. Rowland. In Targeted Drugs. E. P. Goldberg, Ed. Wiley-Interscience, New York, 1983. |
|
|
|
|
|
|
|
|
188. M. V. Primm, et al. Cancer Immunol. Immunother. 12: 125, 1982. |
|
|
|
|
|
|
|
|
189. M. Muirhead, et al. Blood 62: 327, 1983. |
|
|
|
|
|
|
|
|
190. R. Duncan, et al. J. Cancer 55: 165, 1987. |
|
|
|
|
|
|
|
|
191. K. S. Houck and L. Huang. Biochem. Biophys. Res. Commun. 145: 1205, 1987. |
|
|
|
|
|
|
|
|
192. G. F. Rowland, et al. Protides Biol. Fluids 30: 375, 1983. |
|
|
|
|
|
|
|
|
193. J. Corvalan, et al. Protides Biol. Fluids 31: 921, 1984. |
|
|
|
|
|
|
|
|
194. M. J. Embleton, et al. Br. J. Cancer 43: 582, 1981. |
|
|
|
|
|
|
|
|
195. J. P. Brown, et al. J. Immunol. 127: 539, 1981. |
|
|
|
|
|
|
|
|
196. J. T. Kemshed. Hybridoma 1: 109, 1982. |
|
|
|
|
|
|
|
|
197. M. J. Embleton, et al. Br. J. Cancer 47: 49, 1983. |
|
|
|
|
|